Nyxoah Ownership
| NYXH Stock | USD 10.91 0.86 8.56% |
Nyxoah |
Nyxoah Stock Ownership Analysis
About 38.0% of the company outstanding shares are owned by corporate insiders. The book value of Nyxoah was now reported as 3.05. The company recorded a loss per share of 1.78. Nyxoah had not issued any dividends in recent years. Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. Nyxoah S is traded on NASDAQ Exchange in the United States. To find out more about Nyxoah contact Olivier Taelman at 32 10 22 23 55 or learn more at https://www.nyxoah.com.Besides selling stocks to institutional investors, Nyxoah also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Nyxoah's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Nyxoah's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Nyxoah Quarterly Liabilities And Stockholders Equity |
|
About 38.0% of Nyxoah are currently held by insiders. Unlike Nyxoah's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Nyxoah's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Nyxoah's insider trades
Nyxoah Outstanding Bonds
Nyxoah issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nyxoah uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nyxoah bonds can be classified according to their maturity, which is the date when Nyxoah has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| International Game Technology Corp BondUS460599AD57 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Nyxoah Corporate Filings
6K | 2nd of January 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 8th of November 2024 Other Reports | ViewVerify | |
F3 | 10th of October 2024 An amendment to the original Schedule 13D filing | ViewVerify |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nyxoah. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more detail on how to invest in Nyxoah Stock please use our How to Invest in Nyxoah guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nyxoah. If investors know Nyxoah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nyxoah listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.78) | Revenue Per Share | Quarterly Revenue Growth 0.297 | Return On Assets | Return On Equity |
The market value of Nyxoah is measured differently than its book value, which is the value of Nyxoah that is recorded on the company's balance sheet. Investors also form their own opinion of Nyxoah's value that differs from its market value or its book value, called intrinsic value, which is Nyxoah's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nyxoah's market value can be influenced by many factors that don't directly affect Nyxoah's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nyxoah's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nyxoah is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nyxoah's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.